Home > Insider Trading > Filing (0001209191-22-042264)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840574	Verve Therapeutics Inc.	VERV	Pharmaceutical Preparations (2834)	824800132

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1864116	Andrew Bellinger	C/O Verve Therapeutics, Inc. 500 Technology Square, Suite 901 Cambridge MA 02139	Cso & Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-07-13	10,000	$1.48	16,629	No	4	M	Direct
Common Stock	Disposition	2022-07-13	10,000	$24.90	6,629	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2022-07-13	10,000	$0.00	10,000	$1.48

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
136,995		2029-09-16	No	4	M	Direct

Footnotes

Includes 1,629 shares of the Company's common stock acquired under the Verve Therapeutics, Inc. Amended and Restated 2021 Employee Stock Purchase Plan.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2022.
The remaining shares underlying this option, which was granted on September 17, 2019 and commenced vesting on October 1, 2019, vest in equal monthly installments until October 1, 2023.